{
    "code": "02023205",
    "time": "2015-06-25 17:35:13",
    "許可證字號": "衛署藥輸字第023205號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/05\/31",
    "註銷理由": "屆期未申請展延",
    "有效日期": "95\/06\/18",
    "發證日期": "90\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202320502",
    "中文品名": "利必妥合併療法（因治隆注射液一千五百萬單位\/毫升合併瑞比達膠",
    "英文品名": "REBETRON COMBINATION THERAPY PAK (INTRON A 15 MIU\/ML PLUS REBETOL 200MG\/CAP)",
    "適應症": "１．曾經使用　Ａ─ＩＮＴＥＲＦＥＲＯＮ單一療法治療後又復發的慢性Ｃ型肝炎。２．首次接受治療的慢性Ｃ型肝炎。",
    "劑型": "270注射劑",
    "包裝": "盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "INTERFERON ALPHA- 2B, RIBAVIRIN",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0617801100  先靈葆雅企業股份有限公司",
    "申請商地址": "臺北市中山區民權東路三段４號９樓",
    "主製造廠": {
        "製造廠名稱": "F230015000  SCHERING-PLOUGH (BRINNY) COMPANY",
        "製造廠廠址": "INNISHANNON, CO. CORK,",
        "製造廠公司地址": "",
        "製造廠國別": "IRELAND",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818000710",
            "成分名稱": "INTERFERON ALPHA- 2B",
            "含量描述": "15000000",
            "含量": "15000000.0000000000",
            "單位": "IU (I"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "0818000800",
            "成分名稱": "RIBAVIRIN",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}